Report Detail
Global Anti-Obesity Prescription Market Insights, Forecast to 2025
- RnM2389479 |
- 29 July, 2020 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
Anti-Obesity Prescription market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Obesity Prescription market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Anti-Obesity Prescription market is segmented into
Bupropion and Naltrexone
Orlistat
Lorcaserin
Phentermine and Topiramate
Liraglutide
Segment by Application, the Anti-Obesity Prescription market is segmented into
Hospital Pharmacies
Retail Pharmacies
E-Commerce
Regional and Country-level Analysis
The Anti-Obesity Prescription market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anti-Obesity Prescription market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anti-Obesity Prescription Market Share Analysis
Anti-Obesity Prescription market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti-Obesity Prescription business, the date to enter into the Anti-Obesity Prescription market, Anti-Obesity Prescription product introduction, recent developments, etc.
The major vendors covered:
Zydus Cadila
Akrimax Pharmaceuticals
Zealand Pharma
Arrowhead Research
Arena Pharmaceuticals
Compellis Pharmaceuticals
Yungjin Pharm
Alpex Pharma
Bridge BioResearch
1 Study Coverage
- 1.1 Anti-Obesity Prescription Product Introduction
- 1.2 Market Segments
- 1.3 Key Anti-Obesity Prescription Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Anti-Obesity Prescription Market Size Growth Rate by Type
- 1.4.2 Bupropion and Naltrexone
- 1.4.3 Orlistat
- 1.4.4 Lorcaserin
- 1.4.5 Phentermine and Topiramate
- 1.4.6 Liraglutide
- 1.5 Market by Application
- 1.5.1 Global Anti-Obesity Prescription Market Size Growth Rate by Application
- 1.5.2 Hospital Pharmacies
- 1.5.3 Retail Pharmacies
- 1.5.4 E-Commerce
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Anti-Obesity Prescription Market Size, Estimates and Forecasts
- 2.1.1 Global Anti-Obesity Prescription Revenue 2015-2026
- 2.1.2 Global Anti-Obesity Prescription Sales 2015-2026
- 2.2 Global Anti-Obesity Prescription, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Anti-Obesity Prescription Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Anti-Obesity Prescription Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Anti-Obesity Prescription Competitor Landscape by Players
- 3.1 Anti-Obesity Prescription Sales by Manufacturers
- 3.1.1 Anti-Obesity Prescription Sales by Manufacturers (2015-2020)
- 3.1.2 Anti-Obesity Prescription Sales Market Share by Manufacturers (2015-2020)
- 3.2 Anti-Obesity Prescription Revenue by Manufacturers
- 3.2.1 Anti-Obesity Prescription Revenue by Manufacturers (2015-2020)
- 3.2.2 Anti-Obesity Prescription Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Anti-Obesity Prescription Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Anti-Obesity Prescription Revenue in 2019
- 3.2.5 Global Anti-Obesity Prescription Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Anti-Obesity Prescription Price by Manufacturers
- 3.4 Anti-Obesity Prescription Manufacturing Base Distribution, Product Types
- 3.4.1 Anti-Obesity Prescription Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Anti-Obesity Prescription Product Type
- 3.4.3 Date of International Manufacturers Enter into Anti-Obesity Prescription Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Anti-Obesity Prescription Market Size by Type (2015-2020)
- 4.1.1 Global Anti-Obesity Prescription Sales by Type (2015-2020)
- 4.1.2 Global Anti-Obesity Prescription Revenue by Type (2015-2020)
- 4.1.3 Anti-Obesity Prescription Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Anti-Obesity Prescription Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Anti-Obesity Prescription Sales Forecast by Type (2021-2026)
- 4.2.2 Global Anti-Obesity Prescription Revenue Forecast by Type (2021-2026)
- 4.2.3 Anti-Obesity Prescription Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Anti-Obesity Prescription Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Anti-Obesity Prescription Market Size by Application (2015-2020)
- 5.1.1 Global Anti-Obesity Prescription Sales by Application (2015-2020)
- 5.1.2 Global Anti-Obesity Prescription Revenue by Application (2015-2020)
- 5.1.3 Anti-Obesity Prescription Price by Application (2015-2020)
- 5.2 Anti-Obesity Prescription Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Anti-Obesity Prescription Sales Forecast by Application (2021-2026)
- 5.2.2 Global Anti-Obesity Prescription Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Anti-Obesity Prescription Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Anti-Obesity Prescription by Country
- 6.1.1 North America Anti-Obesity Prescription Sales by Country
- 6.1.2 North America Anti-Obesity Prescription Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Anti-Obesity Prescription Market Facts & Figures by Type
- 6.3 North America Anti-Obesity Prescription Market Facts & Figures by Application
7 Europe
- 7.1 Europe Anti-Obesity Prescription by Country
- 7.1.1 Europe Anti-Obesity Prescription Sales by Country
- 7.1.2 Europe Anti-Obesity Prescription Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Anti-Obesity Prescription Market Facts & Figures by Type
- 7.3 Europe Anti-Obesity Prescription Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Anti-Obesity Prescription by Region
- 8.1.1 Asia Pacific Anti-Obesity Prescription Sales by Region
- 8.1.2 Asia Pacific Anti-Obesity Prescription Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Anti-Obesity Prescription Market Facts & Figures by Type
- 8.3 Asia Pacific Anti-Obesity Prescription Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Anti-Obesity Prescription by Country
- 9.1.1 Latin America Anti-Obesity Prescription Sales by Country
- 9.1.2 Latin America Anti-Obesity Prescription Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Anti-Obesity Prescription Market Facts & Figures by Type
- 9.3 Central & South America Anti-Obesity Prescription Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Anti-Obesity Prescription by Country
- 10.1.1 Middle East and Africa Anti-Obesity Prescription Sales by Country
- 10.1.2 Middle East and Africa Anti-Obesity Prescription Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Anti-Obesity Prescription Market Facts & Figures by Type
- 10.3 Middle East and Africa Anti-Obesity Prescription Market Facts & Figures by Application
11 Company Profiles
- 11.1 Zydus Cadila
- 11.1.1 Zydus Cadila Corporation Information
- 11.1.2 Zydus Cadila Description and Business Overview
- 11.1.3 Zydus Cadila Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Zydus Cadila Anti-Obesity Prescription Products Offered
- 11.1.5 Zydus Cadila Related Developments
- 11.2 Akrimax Pharmaceuticals
- 11.2.1 Akrimax Pharmaceuticals Corporation Information
- 11.2.2 Akrimax Pharmaceuticals Description and Business Overview
- 11.2.3 Akrimax Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Akrimax Pharmaceuticals Anti-Obesity Prescription Products Offered
- 11.2.5 Akrimax Pharmaceuticals Related Developments
- 11.3 Zealand Pharma
- 11.3.1 Zealand Pharma Corporation Information
- 11.3.2 Zealand Pharma Description and Business Overview
- 11.3.3 Zealand Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Zealand Pharma Anti-Obesity Prescription Products Offered
- 11.3.5 Zealand Pharma Related Developments
- 11.4 Arrowhead Research
- 11.4.1 Arrowhead Research Corporation Information
- 11.4.2 Arrowhead Research Description and Business Overview
- 11.4.3 Arrowhead Research Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Arrowhead Research Anti-Obesity Prescription Products Offered
- 11.4.5 Arrowhead Research Related Developments
- 11.5 Arena Pharmaceuticals
- 11.5.1 Arena Pharmaceuticals Corporation Information
- 11.5.2 Arena Pharmaceuticals Description and Business Overview
- 11.5.3 Arena Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Arena Pharmaceuticals Anti-Obesity Prescription Products Offered
- 11.5.5 Arena Pharmaceuticals Related Developments
- 11.6 Compellis Pharmaceuticals
- 11.6.1 Compellis Pharmaceuticals Corporation Information
- 11.6.2 Compellis Pharmaceuticals Description and Business Overview
- 11.6.3 Compellis Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Compellis Pharmaceuticals Anti-Obesity Prescription Products Offered
- 11.6.5 Compellis Pharmaceuticals Related Developments
- 11.7 Yungjin Pharm
- 11.7.1 Yungjin Pharm Corporation Information
- 11.7.2 Yungjin Pharm Description and Business Overview
- 11.7.3 Yungjin Pharm Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Yungjin Pharm Anti-Obesity Prescription Products Offered
- 11.7.5 Yungjin Pharm Related Developments
- 11.8 Alpex Pharma
- 11.8.1 Alpex Pharma Corporation Information
- 11.8.2 Alpex Pharma Description and Business Overview
- 11.8.3 Alpex Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Alpex Pharma Anti-Obesity Prescription Products Offered
- 11.8.5 Alpex Pharma Related Developments
- 11.9 Bridge BioResearch
- 11.9.1 Bridge BioResearch Corporation Information
- 11.9.2 Bridge BioResearch Description and Business Overview
- 11.9.3 Bridge BioResearch Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Bridge BioResearch Anti-Obesity Prescription Products Offered
- 11.9.5 Bridge BioResearch Related Developments
- 11.1 Zydus Cadila
- 11.1.1 Zydus Cadila Corporation Information
- 11.1.2 Zydus Cadila Description and Business Overview
- 11.1.3 Zydus Cadila Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Zydus Cadila Anti-Obesity Prescription Products Offered
- 11.1.5 Zydus Cadila Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Anti-Obesity Prescription Market Estimates and Projections by Region
- 12.1.1 Global Anti-Obesity Prescription Sales Forecast by Regions 2021-2026
- 12.1.2 Global Anti-Obesity Prescription Revenue Forecast by Regions 2021-2026
- 12.2 North America Anti-Obesity Prescription Market Size Forecast (2021-2026)
- 12.2.1 North America: Anti-Obesity Prescription Sales Forecast (2021-2026)
- 12.2.2 North America: Anti-Obesity Prescription Revenue Forecast (2021-2026)
- 12.2.3 North America: Anti-Obesity Prescription Market Size Forecast by Country (2021-2026)
- 12.3 Europe Anti-Obesity Prescription Market Size Forecast (2021-2026)
- 12.3.1 Europe: Anti-Obesity Prescription Sales Forecast (2021-2026)
- 12.3.2 Europe: Anti-Obesity Prescription Revenue Forecast (2021-2026)
- 12.3.3 Europe: Anti-Obesity Prescription Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Anti-Obesity Prescription Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Anti-Obesity Prescription Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Anti-Obesity Prescription Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Anti-Obesity Prescription Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Anti-Obesity Prescription Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Anti-Obesity Prescription Sales Forecast (2021-2026)
- 12.5.2 Latin America: Anti-Obesity Prescription Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Anti-Obesity Prescription Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Anti-Obesity Prescription Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Anti-Obesity Prescription Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Anti-Obesity Prescription Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Anti-Obesity Prescription Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Anti-Obesity Prescription Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Anti-Obesity Prescription Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Anti-Obesity Prescription . Industry analysis & Market Report on Anti-Obesity Prescription is a syndicated market report, published as Global Anti-Obesity Prescription Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Anti-Obesity Prescription market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
